Hunan Warrant Pharmaceutical Co.,Ltd (SHA:688799)
China flag China · Delayed Price · Currency is CNY
46.28
+0.08 (0.17%)
Feb 4, 2026, 11:29 AM CST

SHA:688799 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
195.94177.74379.65191.29353.3979.02
Short-Term Investments
-296.78349.66181.66--
Trading Asset Securities
10018315325400-
Cash & Short-Term Investments
295.94657.52744.31697.95753.3979.02
Cash Growth
-15.47%-11.66%6.64%-7.36%853.42%11.40%
Accounts Receivable
233.18226.19183.54180.54129.2137.1
Other Receivables
12.6416.52.142.191.490.69
Receivables
245.83242.69185.68182.73130.68137.78
Inventory
411412.43362.67339.26300.53187.65
Prepaid Expenses
-2.481.111.832.491.23
Other Current Assets
473.54118.1555.9826.5718.8916.4
Total Current Assets
1,4261,4331,3501,2481,206422.08
Property, Plant & Equipment
775.38687596.78563.76472.98429.34
Long-Term Investments
202.0843.4947.1536.0534.117.07
Goodwill
-32.3832.3832.38--
Other Intangible Assets
165.28186.0976.6281.0657.5640.22
Long-Term Deferred Tax Assets
28.5239.8118.7314.212.299.56
Long-Term Deferred Charges
18.810.445.323.260.23-
Other Long-Term Assets
164.4927.1450.2129.9214.3812.85
Total Assets
2,7812,4602,1772,0091,798921.12
Accounts Payable
99.04139.9289.571.1380.944.47
Accrued Expenses
15.1724.5126.0420.6172.81110.12
Short-Term Debt
-3.77----
Current Portion of Long-Term Debt
0.230.050.01---
Current Income Taxes Payable
18.7413.329.971.290.940.36
Current Unearned Revenue
95.8888.9980.1382.4162.7530.27
Other Current Liabilities
105.71148.46130.73119.442.1937.83
Total Current Liabilities
334.76419.02336.38294.83259.59223.05
Long-Term Debt
352.18113.9317.11---
Long-Term Unearned Revenue
101.7898.849.9453.1956.9235
Long-Term Deferred Tax Liabilities
-0.02-2.330.010.02
Other Long-Term Liabilities
-5.285.28-1.55-
Total Liabilities
788.72637.06408.7350.35318.07258.07
Common Stock
131.3293.893.893.893.870.3
Additional Paid-In Capital
850.69850.34850.34850.34850.34218.18
Retained Earnings
1,010859.27779.37652.47535.33374.57
Total Common Equity
1,9921,8031,7241,5971,479663.05
Minority Interest
-19.1744.7362.01--
Shareholders' Equity
1,9921,8231,7681,6591,479663.05
Total Liabilities & Equity
2,7812,4602,1772,0091,798921.12
Total Debt
352.41117.7517.12---
Net Cash (Debt)
-56.47539.77727.19697.95753.3979.02
Net Cash Growth
--25.77%4.19%-7.36%853.42%11.40%
Net Cash Per Share
-0.434.115.535.326.730.80
Filing Date Shares Outstanding
131.32131.32131.32131.32131.3298.42
Total Common Shares Outstanding
131.32131.32131.32131.32131.3298.42
Working Capital
1,0921,0141,013953.5946.38199.02
Book Value Per Share
15.1713.7313.1212.1611.276.74
Tangible Book Value
1,8271,5851,6151,4831,422622.83
Tangible Book Value Per Share
13.9112.0712.2911.2910.836.33
Buildings
-329.86325.35313.1304.86296.87
Machinery
-526.21491.33372.49274.63214.64
Construction In Progress
-143.0627.6270.543.0535.68
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.